ArticleBone marrow transplantation2021
Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis.
Shuhei Kurosawa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it